Multi-level factors associated with more intensive use of radioactive iodine for low-risk thyroid cancer. Wallner LP, Banerjee M, Reyes-Gastelum D, Hamilton AS, et al. J Clin Endocrinol Metab 2021 Mar 4. pii: 6158968. doi: 10.1210.

Read + Share

Amedeo Smart

Independent Medical Education

Wallner LP, Banerjee M, Reyes-Gastelum D, Hamilton AS, et al. Multi-level factors associated with more intensive use of radioactive iodine for low-risk thyroid cancer. J Clin Endocrinol Metab 2021 Mar 4. pii: 6158968. doi: 10.1210.
PMID: 33687063